Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.64
-0.28 (-0.97%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Global Health and Education Projects and Kano Independent Research Centre Trust Sign Strategic Partnership to Support Researchers in Africa
February 26, 2024
Via
AB Newswire
7 Defensive Stocks to Weather Any Downturn With Ease
February 26, 2024
While circumstances may look favorable in the market, it doesn’t hurt for investors to consider defensive stocks – just in case.
Via
InvestorPlace
3 Blue-Chip Stocks to Buy to Bolster Your Portfolio
February 26, 2024
Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare.
Via
InvestorPlace
3 Steal-of-a-Deal Stocks to Snap Up Right Now
February 26, 2024
Here are three steal-of-a-deal stocks that offer meaningful upside for investors looking for stocks that are on sale now.
Via
InvestorPlace
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and...
Via
Benzinga
Better Bull Market Buy: Novavax vs. Pfizer
February 22, 2024
Bull markets usually favor stocks with promising growth prospects.
Via
The Motley Fool
Pfizer Unusual Options Activity For February 21
February 21, 2024
Via
Benzinga
Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors
February 26, 2024
Zealand Pharma's drug showed positive results in 83% of patients in Phase 2 trials for MASH, heating up the race for new obesity drugs and pushing the company's shares 30% higher.
Via
Benzinga
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 26, 2024
From
Pfizer Inc.
Via
Business Wire
7 Struggling Stocks to Sell Before Q2 2024
February 26, 2024
When you have stocks to sell, you also have an opportunity to reallocate that money into investments with a better growth window.
Via
InvestorPlace
Getting a Tax Refund? This Warren Buffett Stock Is a Great Way to Put It to Work
February 24, 2024
This Warren Buffett stock is a safe and proven capital appreciation vehicle.
Via
The Motley Fool
Novavax’s dispute resolution and upcoming earnings call
February 23, 2024
Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
Exploring NYSE:PFE's dividend characteristics.
February 20, 2024
Exploring PFIZER INC (NYSE:PFE)'s dividend characteristics.
Via
Chartmill
Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth
February 23, 2024
Explore recession-proof stocks thriving in Energy, Health Care, Industrials, and more, offering stability and growth amid economic turmoil.
Via
InvestorPlace
3 No-Brainer Stocks to Buy Right Now for Less than $50
February 23, 2024
You won't have to shell out much cash to invest in these great stocks.
Via
The Motley Fool
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
7 Stocks to Buy for Bargain Hunters on the Prowl
February 22, 2024
Wager on these top bargain stocks poised for a comeback, offering both long-term gains and income, away from the growth stock bubble.
Via
InvestorPlace
Why Range-Bound Moderna Could Get A Boost On Its Fourth-Quarter Report
February 22, 2024
The company unexpectedly came in with fourth-quarter earnings that beat projections.
Via
Investor's Business Daily
Moderna Stock Q4 Earnings Preview: RSV mRNA Vaccine Scrutiny, Diminishing Spikevax Revenue, FDA Approval In Focus
February 21, 2024
Moderna reports Q4 earnings on Feb. 22. Analysts expect $2.53B in revenue. Stock has faced challenges but potential for recovery with COVID-19 vaccine and FDA approval in 2024.
Via
Benzinga
Exposures
COVID-19
Product Safety
These 3 Dividend Stocks Yield More Than 5% but Their Payout Ratios Are Over 100%. Are Dividend Cuts Coming?
February 21, 2024
Relying on payout ratio alone can sometimes give investors a misleading picture of just how safe a dividend payment is.
Via
The Motley Fool
3 Cheap Dividend Stocks to Snatch Up Now
February 20, 2024
Cheap dividend stocks offer rebound upside paired with an income source that is difficult to beat for most investors.
Via
InvestorPlace
Get Rich Quick with These 7 Growth Stocks to Buy Now
February 20, 2024
Here are seven growth stocks to buy that will let you know by their price action if the current bull market is ready to expand.
Via
InvestorPlace
Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024
February 20, 2024
The stock market is soaring, and many analysts are worried about a bubble. Still, these seven long-term stocks are still great buys today.
Via
InvestorPlace
2 Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying, and 1 They Can't Sell Fast Enough
February 20, 2024
Two brand-name income stocks with yields north of 6% were gobbled up by prominent billionaires in the December-ended quarter, while a dividend stock with a 15% yield found itself on the chopping...
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Via
Benzinga
European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
February 19, 2024
From
Pfizer Inc.
Via
Business Wire
7 Blue-Chip Stocks to Pick Up While They’re Down
February 18, 2024
Build a robust investment portfolio and make the most of the discount with these blue-chip stocks to buy and hold.
Via
InvestorPlace
ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
February 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX
February 18, 2024
WHY: NEW YORK, NY - (NewMediaWire) - February 18, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 17, 2024
Patience will be rewarded with these stocks.
Via
The Motley Fool
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.